Microwave Spectroscopy

Contains research objectives, summary of research and reports on two research projects.Joint Services Electronics Programs (U. S. Army, U. S. Navy, and U. S. Air Force) under Contract DAAB07-71-C-030

Microwave and Quantum Magnetics

Contains research objectives and reports on nine research projects.Joint Services Electronics Program (Contract DAAG29-80-C-0104)National Science Foundation (Grant 8008628-DAR)U.S. Army (Contract DAAG29-81-K-0126)U.S. Air Force (Contract F19628-79-C-0047

Microwave and Millimeter Wave Techniques

Contains reports on three research projects.Joint Services Electronics Program (Contract DAAB07-75-C-1346

Microwave and Millimeter Wave Techniques

Contains research objectives and summary of research on four research projects.Joint Services Electronics Program (Contract DAAB07-74-C-0630)National Science Foundation (Grant GP-40485X)National Science Foundation (Grant MPS73-05043-A01

Microwave and Millimeter Wave Techniques

Contains reports on three research projects.Joint Services Electronics Program (Contract DAAB07-71-C-0300)National Science Foundation (Grant GP-40485X

Microwave and Quantum Magnetics

Contains research objectives and reports on seven research projects.U.S. Army Research Office (Contract DAAG29-81-K-0126)National Science Foundation (Grant 8008628-DAR)Joint Services Electronics Program (Contract DAAG29-80-C-0104)National Institutes of Health (Grant 1 PO1 CA31303-01

Gestational diabetes mellitus: does one size fit all? A challenge to uniform worldwide diagnostic thresholds

To define the prevalence and pregnancy outcomes related to elevated fasting venous plasma glucose (FVPG) in a Danish pregnancy cohort.This was an observational cohort study including 1,516 women without gestational diabetes mellitus (GDM) by Danish criteria. FVPG measured at 28 weeks' gestation was related to pregnancy outcomes.With use of the World Health Organization 2013 threshold of FVPG ≥5.1 mmol/L, 40.1% of the cohort qualified as having GDM. There was no evidence of excess fetal growth, hypertension in pregnancy, or caesarean delivery in women with FVP